Researchers develop blood test for early-stage ovarian cancer
High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is…
Browsing: ovarian cancer
Combination of cancer vaccine and T cell therapy benefits patients with advanced ovarian cancer
A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with…
Ovarian cancer is not ovarian cancer
Dr Ian Nisbet and Kathy Skoff recently attended an ovarian cancer symposium in Sydney, organised…
Potential target for reversing drug resistance in ovarian cancer identified
For the 314,000 people diagnosed with ovarian cancer each year, platinum-based drugs such as cisplatin…
Ovarian cancer: New biological markers found that may predict which patients won’t respond to chemotherapy
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School…
CAR-T immune therapy attacks ovarian cancer in mice with a single dose
CAR-T immune therapies could be effective against solid tumours if the right targets are identified,…
Signaling between cancer and mesothelial cells promotes ovarian cancer tumourigenesis and immune evasion
Ovarian cancer is the fourth leading cause of cancer mortality amongst women and is characterized…
Why obesity makes ovarian cancer more deadly
Most women with ovarian cancer are diagnosed with the most advanced form of the disease.…
New approach to adoptive T-cell therapy shows promise for boosting immune response in ovarian cancer
Researchers from Roswell Park Comprehensive Cancer Center, USA, report that a new approach to immunotherapy…
Synoptic reporting improves pretreatment CT for advanced ovarian cancer
According to an accepted manuscript published in the American Journal of Roentgenology (AJR), a synoptic report improved…